U.S. flag

An official website of the United States government

Filters

Test type

Test purpose

Test method

Test service

Laboratory certification

Specimen type

See more specimen types...

Laboratory location

See more states

Other countries

See more countries

Results: 21 to 40 of 83

Tests names and labsConditionsGenes, analytes, and microbesMethods

CustomNext-Cancer®

Ambry Genetics
United States
14791
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CancerNext-Expanded®

Ambry Genetics
United States
12271
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Pheochromocytoma and Paraganglioma Panel

Genetic Services Laboratory University of Chicago
United States
1016
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Cancer Panel

PreventionGenetics, part of Exact Sciences
United States
122117
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Renal Cancer Panel

PreventionGenetics, part of Exact Sciences
United States
3325
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Paraganglioma-Pheochromocytoma (PGL/PCC) Syndrome Panel

PreventionGenetics, part of Exact Sciences
United States
1313
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MitoMet®Plus aCGH Analysis

Baylor Genetics
United States
842637
  • D Deletion/duplication analysis

Hereditary Paraganglioma-Pheochromocytoma Syndrome via the SDHC Gene

PreventionGenetics, part of Exact Sciences
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

GIST [detection of somatic mutations: KIT (exons 8 - 11, 13, 17 and 18), PDGFRA (exons 12, 14 and 18), BRAF (V600), CBL (exons 8 and 9), SDHA (whole coding region), SDHB (whole coding region), SDHC (whole coding region) and SDHD (whole coding region)]

CGC Genetics Unilabs
Portugal
38
  • E Sequence analysis of select exons

Hereditary Paraganglioma-Pheochromocytoma Expanded Panel, Sequencing and Deletion/Duplication

ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories
United States
1212
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

SDHC

Institute of Human Genetics Medical University Innsbruck
Austria
31
  • S Mutation scanning of the entire coding region
  • C Sequence analysis of the entire coding region

Inherited Cancer Panel

Dhiti Omics Technologies Private Ltd
India
13684
  • C Sequence analysis of the entire coding region

Hereditary pediatric cancer panel. NGS panel of 71 genes.

Genologica Medica
Spain
15871
  • C Sequence analysis of the entire coding region

Hereditary endocrine cancer panel. NGS panel of 22 genes.

Genologica Medica
Spain
6822
  • C Sequence analysis of the entire coding region

Hereditary kidney cancer panel. NGS panel of 26 genes.

Genologica Medica
Spain
7426
  • C Sequence analysis of the entire coding region

Hereditary Paraganglioma-Pheochromocytoma

Genologica Medica
Spain
3212
  • C Sequence analysis of the entire coding region

Renal cancer

Asper Biogene Asper Biogene LLC
Estonia
4825
  • C Sequence analysis of the entire coding region

Mitochondrial genome sequencing

Molecular Vision Laboratory
United States
526339
  • C Sequence analysis of the entire coding region

VistaSeq Comprehensive Cancer Panel

Molecular Diagnostic Laboratory LabCorp
United States
4759
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

SDHC

Institute for Human Genetics University Medical Center Freiburg
Germany
31
  • C Sequence analysis of the entire coding region

Results: 21 to 40 of 83

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.